Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule
← catalyst calendarNCT06206135 · readout in 542 d
Sponsored by LG Chem (industry) · 051910.KS — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
172estimated
Sites
1
Country
South Korea
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-09-03
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-12-21 | actual | When the study began enrolling |
| Primary completion | 2028-02-28 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2024-01-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-09-03 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Hyperphosphatemia
Intervention
- Drug: the low-dose group (1.5 g/day) or the standard-dose group (4 g/day)
Primary outcome
what the primary-completion date above is the date OFRatio of reached target serum phosphorus level (3.5 - 5.5 mg/dL) at week 48
measured 48 weeks
Related
051910.KS · their whole pipeline
051910.KS's other studiesmost recently updated first
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series Phase 2/3 · Completed
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series Phase 2/3 · Active, not recruiting
- Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET). Phase 4 · Active, not recruiting
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation Phase 1/2 · Not yet recruiting
- A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty Phase 4 · Recruiting
Permalink · 051910.KS's whole pipeline · Catalyst calendar · Every registered study · What changed